NovaBridge Biosciences beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.12 | — | — | Miss |
| Q12026 FY2026 | $-0.12 | $-0.04 | +66.7% | Beat |
| Q12026 FY2026 | $-0.12 | — | — | Miss |
| Q12026 FY2026 | $-0.12 | $-0.04 | +66.7% | Beat |
| Q12026 FY2026 | $-0.12 | — | — | Miss |
| 2026-03-05 | $-0.05 | — | — | Miss |
Back to NBP overview · NBP holders · NBP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.